How to Apply for the PLI Scheme for the Pharmaceuticals Industry in India?

The Production Linked Incentive (PLI) scheme introduced by the Indian government in the pharmaceutical sector is aimed at revolutionizing domestic manufacturing, reducing import dependence, and promoting innovation in the industry. This scheme holds the potential to transform India into a global leader in pharmaceutical production and enhance its self-sufficiency in critical bulk drugs and Active Pharmaceutical Ingredients (APIs). By providing financial incentives based on incremental sales and setting criteria for eligibility, the scheme seeks to incentivize participants to invest in new greenfield plants, expand existing facilities, and contribute to the growth of the sector. However, participating in the PLI scheme comes with its own set of challenges. Participants must navigate hurdles such as substantial investment requirements, scaling up production, ensuring compliance with stringent regulations, and competing in a dynamic market. By capitalizing on the incentives and effectively managing the associated challenges, participants can position themselves as key players in the Indian pharmaceutical landscape, driving innovation, and contributing to the country's overall economic growth.

To learn more about the features and eligibility – CLICK HERE.

Why apply for the PLI scheme?

As a recipient of the Production Linked Incentive (PLI) scheme in the pharmaceutical sector, there are several significant benefits to be gained –

• Participants in the PLI scheme are eligible for financial incentives based on incremental sales. This provides a substantial boost to their revenue and profitability, encouraging participants to increase production, expand operations, and drive growth in the pharmaceutical sector.
• The PLI scheme aims to reduce India's reliance on imported critical bulk drugs, APIs, and pharmaceutical goods. As a recipient, you can capitalize on this opportunity to enhance domestic manufacturing capabilities, thereby reducing import dependence and ensuring a secure supply of essential pharmaceutical products.
• By participating in the PLI scheme, you gain a competitive edge in the pharmaceutical market. The incentives enable you to invest in research and development, innovate, and produce high-value pharmaceutical goods. This allows you to compete effectively against domestic and international players, enhancing your market presence and positioning.
• The PLI scheme encourages participants to adopt advanced manufacturing technologies, upgrade infrastructure, and improve production processes. This promotes increased productivity and efficiency, leading to cost savings, streamlined operations, and enhanced competitiveness in the market.
• The PLI scheme places a strong emphasis on innovation in the pharmaceutical sector. As a recipient, you are encouraged to invest in research and development, develop new drugs, and enhance existing formulations. This fosters innovation, enables the creation of intellectual property, and strengthens your portfolio of pharmaceutical products.
• The PLI scheme contributes to the development of a robust domestic manufacturing ecosystem in the pharmaceutical sector. By participating in the scheme, you play a vital role in expanding and strengthening the industry, creating employment opportunities, and contributing to the overall economic growth of the country.
• The PLI scheme provides long-term incentives, allowing you to plan and execute strategies for sustained growth. With declining incentive rates over time, the scheme incentivizes participants to invest in building a strong foundation and achieve consistent growth in the pharmaceutical sector.

What are some Key Obligations as a Recipient?

As a recipient of the Production Linked Incentive (PLI) scheme in the pharmaceutical sector, there are certain key obligations that you must fulfil -

• Participants are required to fulfil the investment commitments outlined in the scheme. This includes making the specified capital investments in establishing new greenfield plants or expanding existing facilities within the designated timeframes.
• Recipients must meet the incremental sales targets set under the scheme. These targets are based on the base year sales and require participants to demonstrate growth in sales over the specified period. The achievement of these targets is crucial to qualify for the incentives offered under the scheme.
• Recipients must comply with all relevant laws, regulations, and quality standards governing the pharmaceutical industry. This includes adherence to Good Manufacturing Practices (GMP), regulatory requirements for safety and efficacy, intellectual property rights, and other applicable regulations related to production, labelling, and marketing of pharmaceutical goods.
• Recipients are obligated to provide accurate and timely reports and documentation as per the requirements of the scheme. This includes submitting regular progress reports, financial statements, and any other information specified by the implementing authorities.
• Recipients must maintain proper records and documentation related to their investments, production, sales, and other relevant aspects. These records may be subject to audit and scrutiny to ensure compliance with the scheme guidelines.
• Recipients may be subject to audits, inspections, or evaluations by the implementing authorities or designated agencies. These audits aim to verify compliance, assess performance, and ensure adherence to the obligations and guidelines of the PLI scheme.

How to Pitch for the Scheme?

A manufacturer may need to provide a convincing pitch to the authorities in order to enjoy the benefits of the PLI scheme for the Pharmaceuticals Industry in India. Here are some essential steps to pitch for the PLI scheme:

• Research the PLI scheme for Pharmaceuticals Industry in India: Before you pitch for the PLI scheme, make sure to understand the objectives, requirements and eligibility of the scheme.
• Highlight your company's capabilities: It is important to highlight your company's experience, expertise, and capabilities in the field of Pharmaceuticals. It is important to share the company's track record, production capacity, and quality standards to demonstrate your ability to meet the production targets under the PLI scheme.
• Present your investment and production plans: The PLI scheme for the Pharmaceuticals Industry is designed to encourage investments in its manufacturing in India. Therefore, clearly presenting investment plans, including the amount of investment, the sources of funding, and the timeline for investment is necessary. Also, a clear outline of the production plans and plan to achieve the targets can be beneficial.
• Emphasise the benefits of the PLI scheme: Highlighting the benefits of the PLI scheme for the Pharmaceuticals Industry and how it will help you scale up your manufacturing operations is important.

Process of Application and Disbursement of Incentives:

The Production-Linked Incentive (PLI) scheme for  is an initiative by the Indian government to promote manufacturing in India. To apply for the PLI scheme for the Pharmaceuticals Industry, an eligible manufacturer may follow the following steps-

1.    Register on the PLI portal: You can visit the PLI portal (https://pli-eda.gov.in/) and create an account by providing your basic details.

2.    Fill in the application form: The application form may require you to provide details such as your company name, address, production targets, investment plans, etc.

3.    Upload the required documents: You may also need to upload certain documents such as company registration certificate, PAN card, GST registration, etc.

4.    Submit the application: After filling in the application form and uploading the required documents, you can submit your application for the PLI scheme for the pharmaceuticals industry.

5.    Wait for approval: Once you have submitted your application, it will be reviewed by the PMA. If your application is approved, the incentives shall disburse after completion of all pre-disbursal formalities.

In conclusion, participating in the Production Linked Incentive (PLI) scheme in the pharmaceutical sector comes with both opportunities and obligations. By fulfilling your obligations as a recipient, you can maximize the benefits and contribute to the growth and development of the industry. Key obligations include meeting investment commitments, achieving incremental sales targets, maintaining compliance with regulations, timely reporting and documentation, participating in audits and inspections, sharing knowledge and data, and adhering to scheme guidelines. By meeting these obligations, you demonstrate your commitment to the scheme's objectives of promoting domestic manufacturing, reducing import dependence, and driving innovation in the pharmaceutical sector. Additionally, fulfilling your obligations ensures transparency, accountability, and the efficient utilization of resources provided under the scheme. Adhering to the key obligations as a recipient of the PLI scheme not only allows you to benefit from the incentives offered but also positions you as a responsible and valuable contributor to the growth and success of the pharmaceutical sector in India.